Related references
Note: Only part of the references are listed.B-Lineage Differentiation Stages Resolved by Multiparameter Flow Cytometry
RICHARD R. HARDY et al.
Annals of the New York Academy of Sciences (2010)
BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
Daniel W. Sherbenou et al.
BLOOD (2010)
Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
Mark A. Gregory et al.
CANCER CELL (2010)
Regulated expression of the Ras effector Rin1 in forebrain neurons
Bartholomew Dzudzor et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
Lars Klemm et al.
CANCER CELL (2009)
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Thomas O'Hare et al.
CANCER CELL (2009)
Cell Proliferation and Epidermal Growth Factor Signaling in Non-small Cell Lung Adenocarcinoma Cell Lines Are Dependent on Rin1
Jin C. Tomshine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Chen Zhao et al.
NATURE (2009)
Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation
Christine Dierks et al.
CANCER CELL (2008)
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression
Maria J. Bueno et al.
CANCER CELL (2008)
Enhancement of ABL Kinase Catalytic Efficiency by a Direct Binding Regulator Is Independent of Other Regulatory Mechanisms
Xiaoqing Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tyrosine Phosphorylation in the SH3 Domain Disrupts Negative Regulatory Interactions within the c-Abl Kinase Core
Shugui Chen et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
被撤回的出版物: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin (Retracted article. See vol. 34, pg. 1722, 2020)
L. X. Wu et al.
LEUKEMIA (2008)
Integration of transforming growth factor β and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration
Hailiang Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells
Takeshi Kawano et al.
CANCER RESEARCH (2007)
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
Neil P. Shah et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Signal transduction pathways that contribute to myeloid differentiation
M. B. Miranda et al.
LEUKEMIA (2007)
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants
Brian J. Skaggs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia
Rong Chen et al.
CANCER RESEARCH (2006)
Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase
B Nagar et al.
MOLECULAR CELL (2006)
RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration
HL Hu et al.
CURRENT BIOLOGY (2005)
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
M Deininger et al.
BLOOD (2005)
The BCR-ABL story: Bench to bedside and back
S Wong et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease
S Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The Src homology 2 domain of Rin1 mediates its binding to the epidermal growth factor receptor and regulates receptor endocytosis
MA Barbieri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Autoinhibition of Bcr-Abl through its SH3 domain
KM Smith et al.
MOLECULAR CELL (2003)
Two distinct phosphorylation pathways have additive effects on Abl family kinase activation
KQ Tanis et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL
M Azam et al.
CELL (2003)
Structural basis for the autoinhibition of c-Abl tyrosine kinase
B Nagar et al.
CELL (2003)
Gene expression profile of serial samples of transformed B-cell lymphomas
S de Vos et al.
LABORATORY INVESTIGATION (2003)
Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation
C Talora et al.
GENES & DEVELOPMENT (2002)
Survival signaling mediated by c-Jun NH2-terminal kinase in transformed B lymphoblasts
P Hess et al.
NATURE GENETICS (2002)
Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase
K Dorey et al.
ONCOGENE (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
c-Ab1 has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines
BB Brasher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase
T Schindler et al.
SCIENCE (2000)
Share Paper
